< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
11 - 20 of 75
- Antigen-specific peripheral tolerization and targeted delivery as preventive strategy in mice with late-stage pre-diabetesFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- The use of novel technologies with a focus on the individual needs of people living with type 1 diabetesFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Closed-loop insulin delivery in pregnant women with type 1 diabetes (the CRISTAL study)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant, BOF - doctoral mandates
- The Belgian Diabetes in pregnancy follow-up studyFrom1 Oct 2020 → 9 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Stratification of Obese Phenotypes to Optimize Future Obesity TherapyFrom1 Jun 2020 → TodayFunding: H2020 - European Institute of Innovation and Technology
- Translational research-oriented technology platform for single cell analysisFrom1 May 2020 → TodayFunding: BOF - scientific equipment program
- Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIAFrom1 May 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Citrullinated and deamidated neo-epitopes and their role in murine type 1 diabetes.From1 Jan 2020 → TodayFunding: FWO fellowships
- Impact of high salt diet on Sjögren’s syndrome and type 1 diabetes mellitusFrom1 Oct 2019 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes – time to harvest.From15 Jul 2019 → 14 Jul 2021Funding: BOF - various
Publications
1 - 10 of 713
- Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial.(2024)
Authors: Chantal Mathieu, Christophe Matthys, Annick Bogaerts, Katrien Fouzia Benhalima
Pages: 102523 - Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.(2024)
Authors: Chantal Mathieu
Pages: 729 - 738 - The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Authors: Rita Derua, Chantal Mathieu, Lut Overbergh
Pages: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Authors: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Authors: Chantal Mathieu
Pages: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Authors: Kristina Casteels, Chantal Mathieu
- An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.(2024)
Authors: Chantal Mathieu, Lut Overbergh
Pages: db230622 - A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Authors: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Authors: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)